Association of SGLT2 Inhibitor Initiation and PSA Response in Prostate Cancer
Patients with localized or biochemically recurrent prostate cancer achieved PSA responses to SGLT2 inhibitors. These findings justify prospective studies in patients with prostate cancer.
Authors
- Samuel Ray Denmeade (ORCID: https://orcid.org/0000-0001-5442-515X)
- Michael A. Carducci (ORCID: https://orcid.org/0000-0002-7908-1215)
- Etan R. Aber
- Mark Christopher Markowski (ORCID: https://orcid.org/0000-0003-2780-5100)
- Catherine Handy Marshall (ORCID: https://orcid.org/0000-0002-2653-4110)
- Channing Judith Paller (ORCID: https://orcid.org/0000-0003-3658-1858)
- Kelli Rourke
Institutions
- National Institutes of Health (US)
- Johns Hopkins University (US)
- National Cancer Institute (US)
- Sidney Kimmel Comprehensive Cancer Center (US)
Publication Details
- Journal
- The Prostate
- Published
- 2024-12-22
- DOI
- https://doi.org/10.1002/pros.24841
- Citations
- 3
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.07